{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:43:41Z","timestamp":1794368621641,"version":"4.9.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bacteriophage\u2013antibiotic coadministration is increasingly used for refractory infections, yet the in vivo interactions among phages, bacteria, antibiotics, and host immunity remain poorly defined. We report a longitudinal, multiomic case analysis of a male in his seventies with cystic fibrosis (CF) experiencing an acute-on-chronic pulmonary exacerbation caused by multidrug-resistant (MDR)\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    . After colistin discontinuation due to nephrotoxicity, ciprofloxacin was initiated, with an intravenous two-phage cocktail introduced days later. Distinct mucoid and nonmucoid bacterial subpopulations associated differentially with antibiotic versus phage exposure, consistent with nonoverlapping selective pressures. Phage activity was temporally constrained, with one phage dominating early bacterial and genomic signals before attenuating after approximately seven days, despite continued genomic detectability. In contrast, the second phage showed no evidence of productive activity. This asymmetry coincided with phage-reactive humoral immunity: pre-existing IgM was associated with lack of recoverability of one phage, while treatment-associated IgM emergence temporally tracked attenuation of the dominant phage. Although phage-resistant variants arose during therapy, they showed limited expansion relative to susceptible populations. These findings define a mechanistic framework\u2014chemobiotherapy\u2014in which chemical and biological antimicrobials coordinate through ecological and immunologic complementarity rather than direct pharmacologic synergy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-69247-w","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:05:01Z","timestamp":1770768301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ecological partitioning enables phage\u2013antibiotic cooperation in a human Pseudomonas infection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7694-277X","authenticated-orcid":false,"given":"Tiffany","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7193-1543","authenticated-orcid":false,"given":"Lukeman","family":"Kharrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-1449","authenticated-orcid":false,"given":"Kevin","family":"Champagne-Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Melendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2069-8915","authenticated-orcid":false,"given":"Dwayne R.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"69247_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell, S. C. et al. The future of cystic fibrosis care: a global perspective.  Lancet Respiratory Med. 8, 65\u2013124 (2020).","journal-title":"Lancet Respiratory Med."},{"key":"69247_CR2","doi-asserted-by":"publisher","first-page":"e00275","DOI":"10.1128\/mBio.00275-18","volume":"9","author":"S Malhotra","year":"2018","unstructured":"Malhotra, S., Limoli, D. H., English, A. E., Parsek, M. R. & Wozniak, D. J. Mixed communities of mucoid and nonmucoid Pseudomonas aeruginosa exhibit enhanced resistance to host antimicrobials. mBio 9, e00275\u2013e00318 (2018).","journal-title":"mBio"},{"key":"69247_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep10932","volume":"5","author":"ST Clark","year":"2015","unstructured":"Clark, S. T. et al. Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Sci. Rep. 5, 10932 (2015).","journal-title":"Sci. Rep."},{"key":"69247_CR4","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.coi.2023.102328","volume":"83","author":"N Cramer","year":"2023","unstructured":"Cramer, N., Klockgether, J. & T\u00fcmmler, B. Microevolution of Pseudomonas aeruginosa in the airways of people with cystic fibrosis. Curr. Opin. Immunol. 83, 102328 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"69247_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41551-024-01233-3","volume":"9","author":"AA Sousa","year":"2025","unstructured":"Sousa, A. A. et al. Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells. Nat. Biomed. Eng. 9, 7\u201321 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"69247_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","volume":"22","author":"SM Rowe","year":"2023","unstructured":"Rowe, S. M. et al. Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study. J. Cyst. Fibros.: Off. J. Eur. Cyst. Fibros. Soc. 22, 656\u2013664 (2023).","journal-title":"J. Cyst. Fibros.: Off. J. Eur. Cyst. Fibros. Soc."},{"key":"69247_CR7","doi-asserted-by":"publisher","first-page":"e167957","DOI":"10.1172\/JCI167957","volume":"133","author":"DP Nichols","year":"2023","unstructured":"Nichols, D. P. et al. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist. J. Clin. Invest. 133, e167957 (2023).","journal-title":"J. Clin. Invest."},{"key":"69247_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s42003-023-04601-y","volume":"6","author":"M Usui","year":"2023","unstructured":"Usui, M., Yoshii, Y., Thiriet-Rupert, S., Ghigo, J.-M. & Beloin, C. Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance. Commun. Biol. 6, 275 (2023).","journal-title":"Commun. Biol."},{"key":"69247_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52595-w","volume":"15","author":"F Kunisch","year":"2024","unstructured":"Kunisch, F. et al. Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs. Nat. Commun. 15, 8572 (2024).","journal-title":"Nat. Commun."},{"key":"69247_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/evo.12909","volume":"70","author":"A Betts","year":"2016","unstructured":"Betts, A., Gifford, D. R., MacLean, R. C. & King, K. C. Parasite diversity drives rapid host dynamics and evolution of resistance in a bacteria-phage system. Evolution 70, 969\u2013978 (2016).","journal-title":"Evolution"},{"key":"69247_CR11","doi-asserted-by":"publisher","first-page":"eadi0908","DOI":"10.1126\/science.adi0908","volume":"385","author":"A Weimann","year":"2024","unstructured":"Weimann, A. et al. Evolution and host-specific adaptation of Pseudomonas aeruginosa. Science 385, eadi0908 (2024).","journal-title":"Science"},{"key":"69247_CR12","doi-asserted-by":"publisher","first-page":"e3002781","DOI":"10.1371\/journal.pbio.3002781","volume":"22","author":"BH Pedersen","year":"2024","unstructured":"Pedersen, B. H. et al. Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients. PLoS Biol. 22, e3002781 (2024).","journal-title":"PLoS Biol."},{"key":"69247_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1164\/rccm.201407-1381OC","volume":"191","author":"A Hector","year":"2015","unstructured":"Hector, A. et al. Regulatory T-Cell impairment in cystic fibrosis patients with chronic Pseudomonas infection. Am. J. Respir. Crit. Care Med. 191, 914\u2013923 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"69247_CR14","doi-asserted-by":"publisher","first-page":"L394","DOI":"10.1152\/ajplung.00091.2012","volume":"304","author":"BM Fischer","year":"2013","unstructured":"Fischer, B. M. et al. Increased expression of senescence markers in cystic fibrosis airways. Am. J. Physiol.-Lung Cell. Mol. Physiol. 304, L394\u2013L400 (2013).","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"69247_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 7, 199 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"69247_CR16","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41596-020-0346-0","volume":"15","author":"T Luong","year":"2020","unstructured":"Luong, T., Salabarria, A.-C., Edwards, R. A. & Roach, D. R. Standardized bacteriophage purification for personalized phage therapy. Nat. Protoc. 15, 2867\u20132890 (2020).","journal-title":"Nat. Protoc."},{"key":"69247_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","volume":"31","author":"K Champagne-Jorgensen","year":"2023","unstructured":"Champagne-Jorgensen, K., Luong, T., Darby, T. & Roach, D. R. Immunogenicity of bacteriophages. Trends Microbiol. 31, 1058\u20131071 (2023).","journal-title":"Trends Microbiol."},{"key":"69247_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/microorganisms6040125","volume":"6","author":"A Lopes","year":"2018","unstructured":"Lopes, A., Pereira, C. & Almeida, A. Sequential combined effect of phages and antibiotics on the inactivation of Escherichia coli. Microorganisms 6, 125 (2018).","journal-title":"Microorganisms"},{"key":"69247_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1164\/rccm.202102-0461OC","volume":"204","author":"CH Goss","year":"2021","unstructured":"Goss, C. H. et al. A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment. Am. J. Respir. Crit. Care Med. 204, 1295\u20131305 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"69247_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jcf.2015.01.007","volume":"14","author":"VJ Waters","year":"2015","unstructured":"Waters, V. J. et al. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. J. Cyst. Fibros. 14, 755\u2013762 (2015).","journal-title":"J. Cyst. Fibros."},{"key":"69247_CR21","doi-asserted-by":"publisher","first-page":"108835","DOI":"10.1016\/j.isci.2024.108835","volume":"27","author":"TG Liou","year":"2024","unstructured":"Liou, T. G. et al. Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis. iScience 27, 108835 (2024).","journal-title":"iScience"},{"key":"69247_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jcf.2020.11.019","volume":"20","author":"MM Willmering","year":"2021","unstructured":"Willmering, M. M. et al. Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis. J. Cyst. Fibros. 20, 533\u2013539 (2021).","journal-title":"J. Cyst. Fibros."},{"key":"69247_CR23","doi-asserted-by":"publisher","first-page":"e200477","DOI":"10.1148\/ryct.2021200477","volume":"3","author":"KA Hasenstab","year":"2021","unstructured":"Hasenstab, K. A. et al. Automated CT staging of chronic obstructive pulmonary disease severity for predicting disease progression and mortality with a deep learning convolutional neural network. Radiol. Cardiothorac. imaging 3, e200477 (2021).","journal-title":"Radiol. Cardiothorac. imaging"},{"key":"69247_CR24","doi-asserted-by":"crossref","unstructured":"Koo, M. C. et al. Quantitative computed tomography and visual emphysema scores: association with lung function decline. ERJ Open Res. 9, 00523\u20132022 (2023).","DOI":"10.1183\/23120541.00523-2022"},{"key":"69247_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-020-00171-7","volume":"6","author":"M-M Pust","year":"2020","unstructured":"Pust, M.-M. et al. The human respiratory tract microbial community structures in healthy and cystic fibrosis infants. npj Biofilms Microbiomes 6, 61 (2020).","journal-title":"npj Biofilms Microbiomes"},{"key":"69247_CR26","doi-asserted-by":"publisher","first-page":"e0363322","DOI":"10.1128\/spectrum.03633-22","volume":"11","author":"K Pienkowska","year":"2023","unstructured":"Pienkowska, K. et al. The cystic fibrosis upper and lower airway metagenome. Microbiol Spectr. 11, e0363322 (2023).","journal-title":"Microbiol Spectr."},{"key":"69247_CR27","doi-asserted-by":"crossref","unstructured":"Moran Losada, P. et al. The cystic fibrosis lower airways microbial metagenome. ERJ Open Res. 2, 00096\u20132015 (2016).","DOI":"10.1183\/23120541.00096-2015"},{"key":"69247_CR28","doi-asserted-by":"publisher","first-page":"e00984","DOI":"10.1128\/msystems.00984-25","volume":"10","author":"G Tang","year":"2025","unstructured":"Tang, G. et al. Metagenomic estimation of absolute bacterial biomass in the mammalian gut through host-derived read normalization. mSystems 10, e00984\u201300925 (2025).","journal-title":"mSystems"},{"key":"69247_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49150-y","volume":"15","author":"S Widder","year":"2024","unstructured":"Widder, S. et al. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis. Nat. Commun. 15, 4889 (2024).","journal-title":"Nat. Commun."},{"key":"69247_CR30","doi-asserted-by":"publisher","first-page":"992214","DOI":"10.3389\/fcimb.2022.992214","volume":"12","author":"N Cramer","year":"2022","unstructured":"Cramer, N. et al. Competitive fitness of Pseudomonas aeruginosa isolates in human and murine precision-cut lung slices. Front. Cell Infect. Microbiol. 12, 992214 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"69247_CR31","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1128\/AEM.00067-13","volume":"79","author":"DR Roach","year":"2013","unstructured":"Roach, D. R., Sjaarda, D. R., Castle, A. J. & Svircev, A. M. Host exopolysaccharide quantity and composition impact Erwinia amylovora bacteriophage pathogenesis. Appl. Environ. Microbiol. 79, 3249\u20133256 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"69247_CR32","doi-asserted-by":"publisher","first-page":"e41540","DOI":"10.1016\/j.heliyon.2024.e41540","volume":"11","author":"VR Flores-Vega","year":"2025","unstructured":"Flores-Vega, V. R., Partida-Sanchez, S., Ares, M. A., Ortiz-Navarrete, V. & Rosales-Reyes, R. High-risk Pseudomonas aeruginosa clones harboring \u03b2-lactamases: 2024 update. Heliyon 11, e41540 (2025).","journal-title":"Heliyon"},{"key":"69247_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijmm.2010.08.009","volume":"300","author":"A Oliver","year":"2010","unstructured":"Oliver, A. Mutators in cystic fibrosis chronic lung infection: prevalence, mechanisms, and consequences for antimicrobial therapy. Int. J. Med. Microbiol. 300, 563\u2013572 (2010).","journal-title":"Int. J. Med. Microbiol."},{"key":"69247_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1099\/mic.0.063065-0","volume":"159","author":"GC Palmer","year":"2013","unstructured":"Palmer, G. C., Jorth, P. A. & Whiteley, M. The role of two Pseudomonas aeruginosa anthranilate synthases in tryptophan and quorum signal production. Microbiol. (Read.) 159, 959\u2013969 (2013).","journal-title":"Microbiol. (Read.)"},{"key":"69247_CR35","doi-asserted-by":"publisher","first-page":"fnaf017","DOI":"10.1093\/femsle\/fnaf017","volume":"372","author":"I Kyrkou","year":"2025","unstructured":"Kyrkou, I. et al. Pseudomonas aeruginosa maintains an inducible array of novel and diverse prophages over lengthy persistence in cystic fibrosis lungs. FEMS Microbiol. Lett. 372, fnaf017 (2025).","journal-title":"FEMS Microbiol. Lett."},{"key":"69247_CR36","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1469-0691.2010.03250.x","volume":"16","author":"A Oliver","year":"2010","unstructured":"Oliver, A. & Mena, A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16, 798\u2013808 (2010).","journal-title":"Clin. Microbiol. Infect."},{"key":"69247_CR37","doi-asserted-by":"crossref","unstructured":"Schumann, A. R., Sue, A. D. & Roach, D. R. Hypoxia increases the tempo of phage resistance and mutational bottlenecking of Pseudomonas aeruginosa. Front. Microbiol. 13, 905343 (2022).","DOI":"10.3389\/fmicb.2022.905343"},{"key":"69247_CR38","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1111\/1462-2920.13336","volume":"18","author":"D Hocquet","year":"2016","unstructured":"Hocquet, D. et al. Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion, which confers resistance to pyocins. Environ. Microbiol. 18, 3482\u20133493 (2016).","journal-title":"Environ. Microbiol."},{"key":"69247_CR39","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1111\/1462-2920.14924","volume":"22","author":"N Cramer","year":"2020","unstructured":"Cramer, N., Fischer, S., Hedtfeld, S., Dorda, M. & T\u00fcmmler, B. Intraclonal competitive fitness of longitudinal cystic fibrosis Pseudomonas aeruginosa airway isolates in liquid cultures. Environ. Microbiol. 22, 2536\u20132549 (2020).","journal-title":"Environ. Microbiol."},{"key":"69247_CR40","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/molbev\/msv032","volume":"32","author":"PD Scanlan","year":"2015","unstructured":"Scanlan, P. D. et al. Coevolution with bacteriophages drives genome-wide host evolution and constrains the acquisition of abiotic-beneficial mutations. Mol. Biol. Evol. 32, 1425\u20131435 (2015).","journal-title":"Mol. Biol. Evol."},{"key":"69247_CR41","doi-asserted-by":"publisher","first-page":"e01652","DOI":"10.1128\/mBio.01652-19","volume":"10","author":"RCT Wright","year":"2019","unstructured":"Wright, R. C. T., Friman, V. P., Smith, M. C. M. & Brockhurst, M. A. Resistance evolution against phage combinations depends on the timing and order of exposure. mBio 10, e01652\u201301619 (2019).","journal-title":"mBio"},{"key":"69247_CR42","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1159\/000142934","volume":"109","author":"GR Kinsey","year":"2008","unstructured":"Kinsey, G. R., Li, L. & Okusa, M. D. Inflammation in acute kidney injury. Nephron Exp. Nephrol. 109, e102\u2013e107 (2008).","journal-title":"Nephron Exp. Nephrol."},{"key":"69247_CR43","doi-asserted-by":"publisher","first-page":"1250848","DOI":"10.3389\/fmicb.2023.1250848","volume":"14","author":"Q Yang","year":"2023","unstructured":"Yang, Q., Le, S., Zhu, T. & Wu, N. Regulations of phage therapy across the world. Front Microbiol 14, 1250848 (2023).","journal-title":"Front Microbiol"},{"key":"69247_CR44","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan, B. K. et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat. Med. 31, 1494\u20131501 (2025).","journal-title":"Nat. Med."},{"key":"69247_CR45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.medj.2024.05.017","volume":"5","author":"M Bernab\u00e9u-Gimeno","year":"2024","unstructured":"Bernab\u00e9u-Gimeno, M. et al. Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients. Med 5, 1096\u20131111.e1096 (2024).","journal-title":"Med"},{"key":"69247_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-07047-5","volume":"23","author":"PD Tamma","year":"2022","unstructured":"Tamma, P. D. et al. Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b\/2, multicenter, randomized, double-blind, placebo-controlled trial. Trials 23, 1057 (2022).","journal-title":"Trials"},{"key":"69247_CR47","doi-asserted-by":"crossref","unstructured":"Hahn, A. et al. Bacteriophage therapy for pan-drug-resistant Pseudomonas aeruginosa in two persons with cystic fibrosis. J. Invest. Med. High Impact Case Rep. 11, 23247096231188243 (2023).","DOI":"10.1177\/23247096231188243"},{"key":"69247_CR48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chom.2020.06.002","volume":"28","author":"M Louren\u00e7o","year":"2020","unstructured":"Louren\u00e7o, M. et al. The spatial heterogeneity of the gut limits predation and fosters the coexistence of bacteria and bacteriophages. Cell Host Microbe 28, 390\u2013401.e395 (2020).","journal-title":"Cell Host Microbe"},{"key":"69247_CR49","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","volume":"25","author":"BB Hsu","year":"2019","unstructured":"Hsu, B. B. et al. Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe 25, 803\u2013814.e805 (2019).","journal-title":"Cell Host Microbe"},{"key":"69247_CR50","doi-asserted-by":"publisher","first-page":"e03497","DOI":"10.7554\/eLife.03497","volume":"3","author":"KD Seed","year":"2014","unstructured":"Seed, K. D. et al. Evolutionary consequences of intra-patient phage predation on microbial populations. eLife 3, e03497 (2014).","journal-title":"eLife"},{"key":"69247_CR51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"69247_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60598-4","volume":"16","author":"I Weiner","year":"2025","unstructured":"Weiner, I. et al. Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial. Nat. Commun. 16, 5579 (2025).","journal-title":"Nat. Commun."},{"key":"69247_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","volume":"22","author":"DR Roach","year":"2017","unstructured":"Roach, D. R. et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe 22, 38\u201347 e34 (2017).","journal-title":"Cell Host Microbe"},{"key":"69247_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jcf.2018.07.012","volume":"18","author":"AA Tarique","year":"2019","unstructured":"Tarique, A. A. et al. Differential expression of genes and receptors in monocytes from patients with cystic fibrosis. J. Cyst. Fibros. 18, 342\u2013348 (2019).","journal-title":"J. Cyst. Fibros."},{"key":"69247_CR55","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41467-018-03447-x","volume":"9","author":"Y Minato","year":"2018","unstructured":"Minato, Y. et al. Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole. Nat. Commun. 9, 1003 (2018).","journal-title":"Nat. Commun."},{"key":"69247_CR56","doi-asserted-by":"publisher","first-page":"1293633","DOI":"10.3389\/fcimb.2023.1293633","volume":"13","author":"V Kumar","year":"2023","unstructured":"Kumar, V. et al. Antibiotic adjuvants: a synergistic tool to combat multi-drug resistant pathogens. Front Cell Infect. Microbiol. 13, 1293633 (2023).","journal-title":"Front Cell Infect. Microbiol."},{"key":"69247_CR57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","volume":"20","author":"H West","year":"2019","unstructured":"West, H. et al. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.  Lancet Oncol. 20, 924\u2013937 (2019).","journal-title":"Lancet Oncol."},{"key":"69247_CR58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","volume":"14","author":"R Haddad","year":"2013","unstructured":"Haddad, R. et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.  Lancet Oncol. 14, 257\u2013264 (2013).","journal-title":"Lancet Oncol."},{"key":"69247_CR59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jama.2024.23560","volume":"333","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. Camrelizumab vs placebo in combination with chemotherapy as neoadjuvant treatment in patients with early or locally advanced triple-negative breast cancer: The CamRelief randomized clinical trial. JAMA 333, 673\u2013681 (2025).","journal-title":"JAMA"},{"key":"69247_CR60","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3389\/fmicb.2016.01681","volume":"7","author":"M \u017baczek","year":"2016","unstructured":"\u017baczek, M. et al. Antibody production in response to Staphylococcal MS-1 phage cocktail in patients undergoing phage therapy. Front. Microbiol. 7, 1681 (2016).","journal-title":"Front. Microbiol."},{"key":"69247_CR61","doi-asserted-by":"crossref","unstructured":"Dedrick, R. M. et al. Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection. Nat. Med. 27, 1357\u20131361 (2021).","DOI":"10.1038\/s41591-021-01403-9"},{"key":"69247_CR62","doi-asserted-by":"publisher","first-page":"e03396","DOI":"10.1128\/mbio.03396-23","volume":"15","author":"ME Stellfox","year":"2024","unstructured":"Stellfox, M. E. et al. Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia. mBio 15, e03396\u201303323 (2024).","journal-title":"mBio"},{"key":"69247_CR63","doi-asserted-by":"publisher","first-page":"H1479","DOI":"10.1152\/ajpheart.00136.2016","volume":"310","author":"P Rodriguez-Miguelez","year":"2016","unstructured":"Rodriguez-Miguelez, P. et al. Evidence of microvascular dysfunction in patients with cystic fibrosis. Am. J. Physiol.-Heart Circ. Physiol. 310, H1479\u2013H1485 (2016).","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"69247_CR64","doi-asserted-by":"publisher","first-page":"E2699","DOI":"10.1073\/pnas.1210706109","volume":"109","author":"R Ouchida","year":"2012","unstructured":"Ouchida, R. et al. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc. Natl. Acad. Sci. 109, E2699\u2013E2706 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"69247_CR65","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.4049\/jimmunol.2100424","volume":"207","author":"CM Bojanowski","year":"2021","unstructured":"Bojanowski, C. M., Lu, S. & Kolls, J. K. Mucosal immunity in cystic fibrosis.  J. Immunol. 207, 2901\u20132912 (2021).","journal-title":"J. Immunol."},{"key":"69247_CR66","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jcf.2025.01.016","volume":"24","author":"M Berg","year":"2025","unstructured":"Berg, M. et al. Evidence for altered immune-structural cell crosstalk in cystic fibrosis revealed by single-cell transcriptomics. J. Cyst. Fibros. 24, 849\u2013860 (2025).","journal-title":"J. Cyst. Fibros."},{"key":"69247_CR67","doi-asserted-by":"publisher","first-page":"e28023","DOI":"10.7554\/eLife.28023","volume":"6","author":"J-C Garc\u00eda-Betancur","year":"2017","unstructured":"Garc\u00eda-Betancur, J.-C. et al. Cell differentiation defines acute and chronic infection cell types in Staphylococcus aureus. eLife 6, e28023 (2017).","journal-title":"eLife"},{"key":"69247_CR68","doi-asserted-by":"publisher","first-page":"e1004527","DOI":"10.1371\/journal.ppat.1004527","volume":"10","author":"LH Lam","year":"2014","unstructured":"Lam, L. H. & Monack, D. M. Intraspecies competition for niches in the distal gut dictates transmission during persistent Salmonella infection. PLOS Pathog. 10, e1004527 (2014).","journal-title":"PLOS Pathog."},{"key":"69247_CR69","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/cid\/ciz069","volume":"69","author":"LP Shaw","year":"2019","unstructured":"Shaw, L. P. et al. Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance profiles. Clin. Infect. Dis. 69, 1678\u20131686 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"69247_CR70","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson, J. L., Odencrantz, J. R. & Fedan, K. B. Spirometric reference values from a sample of the general U.S. population. Am. J. Respir. Crit. Care Med. 159, 179\u2013187 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"69247_CR71","doi-asserted-by":"publisher","first-page":"e0190061","DOI":"10.1371\/journal.pone.0190061","volume":"12","author":"DJ Conrad","year":"2017","unstructured":"Conrad, D. J. et al. Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. PLOS ONE 12, e0190061 (2017).","journal-title":"PLOS ONE"},{"key":"69247_CR72","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.3390\/ijms222112050","volume":"22","author":"CB Silveira","year":"2021","unstructured":"Silveira, C. B. et al. Multi-omics study of keystone species in a cystic fibrosis microbiome. Int. J. Mol. Sci. 22, 12050 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"69247_CR73","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"69247_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"69247_CR75","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/bioinformatics\/btz715","volume":"36","author":"FP Breitwieser","year":"2019","unstructured":"Breitwieser, F. P. & Salzberg, S. L. Pavian: interactive analysis of metagenomics data for microbiome studies and pathogen identification. Bioinformatics 36, 1303\u20131304 (2019).","journal-title":"Bioinformatics"},{"key":"69247_CR76","unstructured":"Bushnell, B. BBMap: a fast, accurate, splice-aware aligner. (Lawrence Berkeley National Lab.(LBNL), Berkeley, CA (United States), 2014)."},{"key":"69247_CR77","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","volume":"31","author":"F Murtagh","year":"2014","unstructured":"Murtagh, F. & Legendre, P. Ward\u2019s hierarchical agglomerative clustering method: which algorithms implement Ward\u2019s criterion?. J. Classification 31, 274\u2013295 (2014).","journal-title":"J. Classification"},{"key":"69247_CR78","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput Biol. 19, 455\u2013477 (2012).","journal-title":"J. Comput Biol."},{"key":"69247_CR79","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068\u20132069 (2014).","journal-title":"Bioinformatics"},{"key":"69247_CR80","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1093\/bioinformatics\/btv421","volume":"31","author":"AJ Page","year":"2015","unstructured":"Page, A. J. et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 31, 3691\u20133693 (2015).","journal-title":"Bioinformatics"},{"key":"69247_CR81","doi-asserted-by":"publisher","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2 \u2013 approximately maximum-likelihood trees for large alignments. PLOS ONE 5, e9490 (2010).","journal-title":"PLOS ONE"},{"key":"69247_CR82","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","volume":"52","author":"I Letunic","year":"2024","unstructured":"Letunic, I. & Bork, P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 52, W78\u2013W82 (2024).","journal-title":"Nucleic Acids Res."},{"key":"69247_CR83","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 3, 124 (2018).","journal-title":"Wellcome Open Res"},{"key":"69247_CR84","doi-asserted-by":"crossref","unstructured":"Schwengers, O. et al. Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification.  Microb. Genom. 7, 000685 (2021).","DOI":"10.1099\/mgen.0.000685"},{"key":"69247_CR85","doi-asserted-by":"publisher","first-page":"W16","DOI":"10.1093\/nar\/gkw387","volume":"44","author":"D Arndt","year":"2016","unstructured":"Arndt, D. et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res 44, W16\u2013W21 (2016).","journal-title":"Nucleic Acids Res"},{"key":"69247_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1016-7","volume":"17","author":"K Sprouffske","year":"2016","unstructured":"Sprouffske, K. & Wagner, A. Growthcurver: an R package for obtaining interpretable metrics from microbial growth curves. BMC Bioinforma. 17, 172 (2016).","journal-title":"BMC Bioinforma."},{"key":"69247_CR87","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2013).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69247-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:02:48Z","timestamp":1773932568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69247-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69247"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69247-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2615"}}